Procter & Gamble Health’s Share Price Hits 52-Week High on Stellar Q2 Performance

Procter & Gamble Health Shares Surge on Strong Q2 Earnings

On Tuesday, the share price of Procter & Gamble Health Limited saw an impressive rise, climbing over 8% and reaching a 52-week high of Rs 5,742.40 on the NSE. The market responded positively to the company’s robust Q2FY25 earnings report, which was announced after market hours on Monday, sparking substantial buying interest in the stock.

Solid Financial Performance in Q2FY25

For the second quarter of FY25, Procter & Gamble Health reported a profit after tax (PAT) of Rs 82.33 crore, a notable 26% increase from Rs 65.57 crore in the same period last year. This growth reflects the company’s resilient strategy and effective portfolio management. Additionally, revenue from operations reached Rs 313.41 crore, up by 2.7% from Rs 304.93 crore year-on-year (YoY), with total income amounting to Rs 316.69 crore compared to Rs 310.98 crore last year.

Insights from Management

Milind Thatte, Managing Director of Procter & Gamble Health India, commented on the results, stating, “Our first quarter results represent a sequential improvement. Our strategy centers on a focused portfolio of trusted brands, where performance drives brand choice.” He emphasized the company’s dedication to expanding consumer awareness and deepening relationships with stakeholders, adding, “We continue to invest in initiatives that address the evolving needs of both consumers and healthcare professionals, alongside strengthening our go-to-market model and distribution reach.”

Key Brands and Market Position

As one of India’s largest VMS (vitamins, minerals, and supplements) companies, Procter & Gamble Health manufactures and markets well-known brands like Neurobion, Livogen, SevenSeas, Evion, Polybion, and Nasivion. Globally, P&G is known for its robust portfolio of household brands, including Ariel, Gillette, Head & Shoulders, Olay, Oral-B, Pampers, Tide, Vicks, and Whisper, serving consumers across 70 countries.

Share Price Momentum and Investor Confidence

The share price of Procter & Gamble Health has shown a solid uptrend, gaining 14% on a year-to-date (YTD) basis. In the past week alone, the share price climbed 12%, with a 5.5% rise in the last month. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.